The Liver Meeting 2021-Topline Clinical Research: What this Means for Patients

Topline Clinical Research: What this Means for Patients

Video Transcription

Video Summary

Dr. Trueskin led a patient debrief highlighting key findings from the liver meeting this year. Topics included the impact of COVID-19 on liver health, promising therapies for liver diseases such as alcoholic hepatitis and primary biliary cholangitis, as well as advancements in diagnostics like the GALAD score for hepatocellular carcinoma. Studies also discussed hepatitis B treatment strategies, racial disparities in liver disease, and the global cascade of care for hepatitis B and C. Dr. Trueskin emphasized the need for same-day treatment initiation for hepatitis C in young people who inject drugs to improve cure rates. The findings underscore the importance of public health efforts, advocacy, and continued research to meet elimination targets for liver diseases.

Keywords

liver meeting

COVID-19 impact

liver diseases therapies

hepatitis treatment strategies

racial disparities

public health efforts

research